• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

凝血酶原Salakta:丙氨酸取代谷氨酸-466会降低纤维蛋白原的凝血活性和酯酶活性。

Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity.

作者信息

Miyata T, Aruga R, Umeyama H, Bezeaud A, Guillin M C, Iwanaga S

机构信息

Department of Biology, Faculty of Science, Kyushu University, Fukuoka, Japan.

出版信息

Biochemistry. 1992 Aug 25;31(33):7457-62. doi: 10.1021/bi00148a005.

DOI:10.1021/bi00148a005
PMID:1354985
Abstract

Structural studies on a hereditary abnormal prothrombin, prothrombin Salakta, have been performed to identify the difference responsible for its reduced fibrinogen clotting activity and its reduced esterase activity. Amino acid composition and sequence analyses of a peptide isolated from a lysylendopeptidase digest of the abnormal thrombin indicated that Glu-466 had been replaced by Ala. This amino acid substitution can result from a single nucleotide change in the codon for Glu-466 (GAG----GCG). The model building and the molecular dynamics simulation of thrombin Salakta suggest that the Glu-466----Ala substitution would change the proper conformation around the substrate binding site containing Trp-468, which is a unique surface loop on the thrombin molecule. This is the experimental and theoretical evidence supporting the role of the surface loop containing Trp-468 for the proper conformation of the substrate binding site.

摘要

对一种遗传性异常凝血酶原——凝血酶萨拉克塔进行了结构研究,以确定导致其纤维蛋白原凝血活性降低和酯酶活性降低的差异。从异常凝血酶的赖氨酰内肽酶消化物中分离出的一种肽的氨基酸组成和序列分析表明,谷氨酸-466已被丙氨酸取代。这种氨基酸取代可能是由于谷氨酸-466密码子中的单个核苷酸变化(GAG----GCG)引起的。凝血酶萨拉克塔的模型构建和分子动力学模拟表明,谷氨酸-466----丙氨酸取代会改变包含色氨酸-468的底物结合位点周围的正确构象,色氨酸-468是凝血酶分子上一个独特的表面环。这是支持包含色氨酸-468的表面环对底物结合位点正确构象起作用的实验和理论证据。

相似文献

1
Prothrombin Salakta: substitution of glutamic acid-466 by alanine reduces the fibrinogen clotting activity and the esterase activity.凝血酶原Salakta:丙氨酸取代谷氨酸-466会降低纤维蛋白原的凝血活性和酯酶活性。
Biochemistry. 1992 Aug 25;31(33):7457-62. doi: 10.1021/bi00148a005.
2
Prothrombin Tokushima, a replacement of arginine-418 by tryptophan that impairs the fibrinogen clotting activity of derived thrombin Tokushima.凝血酶原德岛,精氨酸418被色氨酸取代,损害了衍生的德岛凝血酶的纤维蛋白原凝血活性。
Biochemistry. 1987 Feb 24;26(4):1117-22. doi: 10.1021/bi00378a020.
3
Substitution of Gly-548 to Ala in the substrate binding pocket of prothrombin Perijá leads to the loss of thrombin proteolytic activity.凝血酶原佩里贾底物结合口袋中甘氨酸548被丙氨酸取代导致凝血酶蛋白水解活性丧失。
Thromb Haemost. 2002 Feb;87(2):282-7.
4
Prothrombin Frankfurt: a dysfunctional prothrombin characterized by substitution of Glu-466 by Ala.凝血酶原法兰克福型:一种功能异常的凝血酶原,其特征为第466位谷氨酸被丙氨酸替代。
Thromb Haemost. 1995 Feb;73(2):203-9.
5
Functional characterization of thrombin Salakta: an abnormal thrombin derived from a human prothrombin variant.凝血酶Salakta的功能特性:一种源自人凝血酶原变体的异常凝血酶。
Blood. 1988 Mar;71(3):556-61.
6
Genetic analysis and functional characterization of prothrombins Corpus Christi (Arg382-Cys), Dhahran (Arg271-His), and hypoprothrombinemia.
Blood. 1996 Oct 1;88(7):2611-8.
7
Prothrombin Salakta: an abnormal prothrombin characterized by a defect in the active site of thrombin.凝血酶原萨拉克塔:一种异常凝血酶原,其特征是凝血酶活性位点存在缺陷。
Thromb Res. 1984 Jun 15;34(6):507-18. doi: 10.1016/0049-3848(84)90255-x.
8
Single amino acid substitutions dissociate fibrinogen-clotting and thrombomodulin-binding activities of human thrombin.单个氨基酸取代可使人类凝血酶的纤维蛋白原凝血活性和血栓调节蛋白结合活性分离。
Proc Natl Acad Sci U S A. 1991 Aug 1;88(15):6775-9. doi: 10.1073/pnas.88.15.6775.
9
Determination of the amino acid substitution in human prothrombin type 3 (157 Glu leads to Lys) and the localization of a third thrombin cleavage site.人凝血酶原3型中氨基酸取代(157位谷氨酸突变为赖氨酸)的测定及第三个凝血酶切割位点的定位
Br J Haematol. 1983 Jun;54(2):245-54. doi: 10.1111/j.1365-2141.1983.tb02092.x.
10
Prothrombin Saint-Denis: a natural variant with a point mutation resulting in Asp to Glu substitution at position 552 in prothrombin.凝血酶原圣丹尼丝:一种天然变体,存在一个点突变,导致凝血酶原第552位的天冬氨酸被谷氨酸替代。
Br J Haematol. 2006 Mar;132(6):770-3. doi: 10.1111/j.1365-2141.2005.05920.x.

引用本文的文献

1
Structure of prothrombin in the closed form reveals new details on the mechanism of activation.凝血酶原封闭形式的结构揭示了激活机制的新细节。
Sci Rep. 2018 Feb 13;8(1):2945. doi: 10.1038/s41598-018-21304-1.
2
Detection of metals and metalloproteins in the plasma of stroke patients by mass spectrometry methods.通过质谱法检测中风患者血浆中的金属和金属蛋白。
Metallomics. 2012 Oct;4(10):1077-87. doi: 10.1039/c2mt20092a. Epub 2012 Sep 14.
3
Rigidification of the autolysis loop enhances Na(+) binding to thrombin.自溶环的刚性增强了凝血酶对钠离子的结合。
Biophys Chem. 2011 Nov;159(1):6-13. doi: 10.1016/j.bpc.2011.04.003. Epub 2011 Apr 12.
4
Evidence of the E*-E equilibrium from rapid kinetics of Na+ binding to activated protein C and factor Xa.从 Na+与激活蛋白 C 和因子 Xa 的快速动力学结合中观察到 E*-E 平衡。
J Phys Chem B. 2010 Dec 16;114(49):16125-30. doi: 10.1021/jp105502c. Epub 2010 Sep 2.
5
Mutant N143P reveals how Na+ activates thrombin.突变 N143P 揭示了钠离子如何激活凝血酶。
J Biol Chem. 2009 Dec 25;284(52):36175-36185. doi: 10.1074/jbc.M109.069500. Epub 2009 Oct 21.
6
Thrombin.凝血酶
Mol Aspects Med. 2008 Aug;29(4):203-54. doi: 10.1016/j.mam.2008.01.001. Epub 2008 Feb 1.
7
Role of P225 and the C136-C201 disulfide bond in tissue plasminogen activator.P225及C136 - C201二硫键在组织型纤溶酶原激活剂中的作用
Protein Sci. 1998 Aug;7(8):1728-37. doi: 10.1002/pro.5560070807.